LCN2 and chronic obstructive pulmonary disease: In the lung, increased LCN2 expression has been reported in subclinical pulmonary emphysema (11), chronic obstructive pulmonary disease (COPD) (12, 13), acute respiratory distress syndrome (ARDS) (14), as well as in patients with influenza A and SARS-CoV-2 virus infections (15).